[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
January 1992

Inhibitory Effects of Interleukin 6 on ImmunityPossible Implications in Burn Patients

Author Affiliations

From the Baltimore Regional Burn Center, The Johns Hopkins University School of Medicine, Baltimore, Md.

Arch Surg. 1992;127(1):65-69. doi:10.1001/archsurg.1992.01420010079011

• Certain disease states are associated with abnormal increases in the monokine interleukin 6. Increased levels of interleukin 6 have been demonstrated in serum from patients with burns and are associated with systemic increases in endotoxin levels. Using a murine in vitro experimental model, we have studied the effects of interleukin 6 on various measures of immunity. Our data indicate that levels equivalent to the concentrations found in serum of burn victims inhibit T-cell proliferation. The inhibitory effect is dose and time dependent, is specific for T cells, is not due to impairment of interleukin 2 production or of interleukin 2 receptor expression, and is dependent on macrophages. These data suggest that extraordinary increases in interleukin 6 levels may be related to impaired T-cell responses and to an increased susceptibility to infection in the patient with burns.

(Arch Surg. 1992;127:65-69)

Munster AM, Winchurch RA, Keane RM, Shatney CD, Ernst CB, Zuidema GD.  The 'n vitro skin test': a reliable and repeatable assay of immune competence in the surgical patient . Ann Surg . 1981;194:345-360.Article
Ninnemann JL, Fisher JC, Frank HA.  Prolonged survival of human skin allografts following thermal injury . Transplantation . 1978;25:69-72.Article
Miller CL, Baker CC.  Changes in lymphocyte activity after thermal injury . J Clin Invest . 1979;63:202-210.Article
Munster AM, Winchurch RA, Birmingham WJ, Keeling P.  Longitudinal assay of lymphocyte responsiveness in patients with major burns . Ann Surg . 1980;192:772-778.Article
Antonacci AC, Gupta S, Good RA, Shires GT, Fernandes G.  Natural killer and antibody-dependent cytotoxicity following thermal injury in humans . Curr Surg . 1983;40:20-23.
Antonacci AC, Good RA, Gupta S.  T-cell subpopulations following thermal injury . Surgery . 1982;155:1-8.
O'Mahony JB, Wood J, Rodrick ML, Mannick JA.  Changes in T lymphocyte subsets following injury . Ann Surg . 1985;202:580-586.Article
Constantian MB.  Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients . Ann Surg . 1978;188:209-215.Article
Winchurch RA, Thupari JN, Munster AM.  Endotoxemia in burn patients: levels of circulating endotoxins are related to burn size . Surgery . 1987;102:808-812.
Guo Y, Dickerson C, Chrest FJ, Adler WH, Munster AM, Winchurch RA.  Increased levels of circulating interleukin 6 in burn patients . Clin Immunol Immunopathol . 1990;54:361-371.Article
Winchurch R, Togo J, Adler WH.  Supplemental zinc restores antibody formation in cultures of aged spleen cells . Clin Immunol Immunopathol . 1988;49:215-222.Article
Helle M, Brakenhoff JPJ, De Groot ER, Aarden LA.  Interleukin 6 is involved in interleukin 1-induced activities . Eur J Immunol . 1988;18:957-959.Article
Tracey KJ, Fong Y, Hesse DG, et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia . Nature . 1987;330:662-664.Article
Kornbluth RS, Edgington TS.  Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-mediated cellular cytotoxicity by endotoxin . J Immunol . 1986;137:2585-2590.
Akira S, Hirano T, Taga T, Kishimoto T.  Biology and multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF) . FASEB J . 1990;4:2860-2867.
Weissenbach J, Chernajovsky Y, Zeevi M, et al.  Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies . Proc Natl Acad Sci U S A . 1980;77:7152-7156.Article
Baumann H, Jahreis GP, Sauder DN, Koj A.  Human keratinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cells from man, rat and mouse . J Biol Chem . 1984;259:7331-7342.
Houssiau FA, Bukasa K, Sindic CJM, Van Dammes J, Van Snick J.  Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system . Clin Exp Immunol . 1988;71:320-323.
Nakajima K, Martinez-Maza O, Hirano T, et al.  Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV . J Immunol . 1989;142:531-536.
Breen EC, Rezai AR, Nakajima K, et al.  Infection with HIV is associated with elevated IL-6 levels and production . J Immunol . 1990;144:480-484.
Van Oers MHJ, Van Der Heyden AAPAM, Aarden LA.  Interleukin 6 (IL-6) in serum and urine of renal transplant recipients . Clin Exp Immunol . 1988;71:314-319.
Fong Y, Moldawer LL, Marano M, et al.  Endotoxemia elicits increased circulating beta-2-IFN/IL-6 in man . J Immunol . 1989;142:2321-2324.
Ertel W, Faist E, Hueltner L, Storck M, Schildberg FW.  Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma . J Surg Res . 1990;48:622-628.Article
Cromack DT, Porras-Reyes B, Mustoe TA.  Current concepts in wound healing: growth factor and macrophage interaction . J Trauma . 1990;30( (suppl) ):S129-S133.Article
Lotz M, Kekow J, Carson DA.  Transforming growth factor-beta and cellular immune responses in synovial fluids . J Immunol . 1990;144:4189-4194.
Peterson PK, Gekker G, Chao CC, Schut R, Molitor TW, Balfour HH Jr.  Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures . J Immunol . 1991;146:81-84.